Brief: Puma Biotechnology Announces U.S Patent Term Extension For Nerlynx® (Neratinib)

Puma Biotechnology

23/11/2021 21:13

Nov 23 (Reuters) - Puma Biotechnology Inc  PBYI.O :
    * PUMA BIOTECHNOLOGY ANNOUNCES U.S PATENT TERM EXTENSION FOR
NERLYNX® (NERATINIB)
    * PUMA BIOTECHNOLOGY INC - USPTO ISSUED A PATENT TERM
EXTENSION
CERTIFICATE FOR U.S. PATENT NO. 7,399,865, EXTENDING PATENT TERM
FIVE YEARS

Source text for Eikon:  ID:nBw45PdK6a 
Further company coverage:  PBYI.O 

 ((Reuters.Briefs@thomsonreuters.com;))